Yeast study links TOR pathway and agmatinase enzymes to aging
A study in yeast reported that the drug rapalink-1, which acts on the TOR growth pathway, prolonged life, and that agmatinase enzymes help regulate that pathway.
Source: Yeast study links TOR pathway and agmatinase enzymes to aging (x.com). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
The study in yeast reported that the drug rapalink-1, which acts on the TOR pathway linked to cell growth, prolonged life in the organisms tested. According to the text, enzymes called agmatinase help regulate this pathway. When these enzymes were absent, cells grew faster and aged sooner.
The TOR pathway has been studied for years because it takes part in basic cell decisions about growth and nutrient use, processes linked to aging in many organisms. Yeast is a single-celled organism widely used in basic research, and findings in yeast often do not hold in animals or people. The result points to a possible link between growth signals and aging, but it has not been tested in people, and the study does not show that anything similar works in the human body.
What it means
The finding suggests that signals of cell growth and aging may be connected, and that enzymes such as agmatinase take part in that regulation. It is still unknown whether this mechanism exists in humans or could ever be useful for health.
How to read it with care
This result from yeast does not replace a medical consultation. Anyone considering a change in diet, supplements or treatment should talk to a doctor or another qualified health professional.